Triastek Reports Positive FIH Results from Study of T21, a 3D Printed Oral Treatment for Moderate to Severe Ulcerative Colitis
July 21, 2023 04:03 ET
|
Triastek, Inc.
The study verified the ability for Triastek's 3D Microstructure for Colon Targeting (3DμS-CT) to precisely target and release medication in the colonNanjing, July 21, 2023 (GLOBE NEWSWIRE) --...
Triastek Reports Positive FIH Results from Study of T21, a 3D Printed Oral Treatment for Moderate to Severe Ulcerative Colitis
July 20, 2023 07:00 ET
|
Triastek, Inc.
The study verified the ability for Triastek's 3D Microstructure for Colon Targeting (3DμS-CT) to precisely target and release medication in the colon Nanjing, July 20, 2023 (GLOBE NEWSWIRE) --...